60923-227Level 3
AMONDYS 45 (casimersen)
**Product type:** Human Prescription Drug
**Active ingredient:** CASIMERSEN
**Strength:** 50 mg/mL
**Dosage form:** Injection
**Route:** Intravenous
**Labeler:** Sarepta Therapeutics, Inc.
**Marketing category:** NDA (NDA213026)
**Pharmacologic class:** Antisense Oligonucleotide [EPC], Increased Protein Synthesis [PE], Oligonucleotides, Antisense [CS]
GET
/api/v1/systems/ndc_fda/nodes/60923-227Hierarchy Explorer
Loading...
Cross-system equivalences0
No cross-system equivalences mapped for this node.